Home / Letter From The Editor / Nov. 3, 2020

Nov. 3, 2020

Nov 3, 2020

Years ago I delivered a CE for pharmacists on the relation of diabetes and obstructive sleep apnea. I went back and looked at the data, and there was a strong correlation between OSA, hypertension and diabetes.

Typically getting a patient on a CPAP device is the only choice available, but now new research on a well known diabetes drug shows reduction in sleep apnea in these patients, while also reducing A1c and cardiovascular risk.


Check out our feature article from Tarshay Boyd, PharmD. Candidate, LECOM School of Pharmacy, to learn what this medication is.



We can make a difference!


Dave Joffe